Healthcare AI

Overview#

Healthcare AI is now a five-segment market — providers, payers, life sciences, med-device, and public health — each with materially different data, personas, regulators, and integration surfaces. Lumping them together produces vague guidance; treating them separately is the only way to make sensible deployment, sovereignty, and procurement decisions. Provider AI lives inside the EHR and the clinical workflow. Payer AI lives inside the claims and authorisation pipeline. Life-sciences AI lives inside the discovery and trial pipeline. Med-device AI lives inside a regulated SaMD release. Public-health AI lives inside epidemiology, surveillance, and outbreak response.

The category has matured rapidly since 2023. Ambient clinical documentation alone passed an estimated 40 million US encounters in 2025; the FDA has now cleared more than 1,000 AI/ML-enabled medical devices, most of them in radiology; the MHRA's AI Airlock has progressed multiple SaMD candidates through structured testing; and prior-authorisation automation is now a board-level cost lever at most US health plans. Discovery has compressed hit-to-lead by months at the most aggressive sponsors. None of this works without the boring, expensive integration plumbing — and none of it is allowed to escape the regulatory boundary the data sits in.

Yobitel Communications is UK-headquartered and sells healthcare AI through three coupled surfaces. MediQuery is the flagship clinical AI application — a managed clinical-decision-support product for NHS trusts, US health systems, and EU regulated trusts, with inline citations on every claim and an immutable audit trail. The wider Yobitel AI Applications suite hosts partner clinical and life-sciences apps (oncology MDT, radiology triage, ambient scribing, prior-authorisation, pharmacovigilance, trial-matching) curated against the same sovereignty bar. Yobibyte is the managed platform on which customer-built clinical applications are deployed by the customer's own engineering team. All three land on Yobitel NeoCloud UK regions (NCSC OFFICIAL primary, OFFICIAL-SENSITIVE for high-classification estates, with the NHS DSP Toolkit and Cyber Essentials Plus baseline), Yobitel NeoCloud EU regions inside the EU Data Boundary, and HIPAA-aligned partner regions with BAA cover for US health systems. Where the trust's posture requires it, the same surfaces run air-gapped on-premise.

This entry helps you decide which healthcare sub-vertical and deployment mode fits your workload, which regulators and integrations you will be expected to evidence from day one, which Yobitel surface (MediQuery, AI Applications partner app, customer-built Yobibyte app) is the right consumption path, and how to size the rollout against the InferenceBench-grounded model selection that drives Yobibyte's marketplace today.

Personas#

Healthcare AI buyers and users split into four cohorts: clinicians who use the product, operators and informaticians who configure it, governance and assurance leads who sign off on it, and discovery / public-health analysts who run it on de-identified or aggregated data. MediQuery and the partner AI Applications suite are built primarily for the first three; Yobibyte hosts apps the customer builds for the fourth.

• Consultant / attending physician — opens a patient context for a complex case, asks MediQuery for the trust's protocol against the most recent national guidance (NICE, BNF, UpToDate), reviews cited evidence, records an override note when judgement diverges. Cares about citation freshness, refusal modes, and EHR-context fidelity above all else.
• Registrar / resident — runs a high volume of routine lookups (formulary, antimicrobial guidance, sepsis pathway, drug-interaction checks) during shift. Cares about latency budget (under 2 seconds perceived, hard cap five seconds), per-role default surfaces, and mobile-friendly presentation.
• Radiologist — reads imaging studies with AI-assisted triage flagging the worklist priority (stroke, PE, pneumothorax, intracranial haemorrhage). Cares about radiology-PACS integration, DICOM SR output, and false-negative rate by demographic.
• Oncologist / MDT lead — runs the multi-disciplinary team meeting against an LLM-summarised case pack drawn from notes, imaging report, pathology, and trial-match candidates. Cares about traceable summarisation and the structured handover into the trial-matching engine.
• Nurse / advanced clinical practitioner — pulls the local sepsis pathway, NEWS2 escalation criteria, or the trust's resuscitation protocol at the bedside. Cares about a focused role-default surface, large-text presentation, and explicit refusal where the source is not in the trust's authorised knowledge base.
• Pharmacist — cross-references new prescriptions against renal function, allergies, weight-based dosing, and existing medications. Cares about the BNF, DrugBank, and RxNorm connectors, and the precision of dose-adjustment ranges.
• Ambient-scribe user (any clinician) — passive listening during the consultation produces a structured SOAP note, problem list, and proposed orders for sign-off. Cares about speaker diarisation, consent capture, redaction of off-record passages, and the latency between consultation end and note availability.
• RCM analyst / prior-authorisation specialist — runs automated medical-necessity extraction against payer policy and the patient's record, drafts authorisation requests, and triages denials. Cares about the X12 278 round-trip, denial-reason coding, and per-payer policy retrieval.
• Claims investigator / SIU analyst — runs LLM-enriched case files against fraud-graph models on the claims line items. Cares about typology detection (upcoding, unbundling, phantom billing) and traceable evidence on every flagged claim.
• Drug-discovery / translational researcher — runs molecular generation with property objectives, protein-language scoring, and synthetic-control augmentation on de-identified trial data. Cares about ephemeral H100 / H200 / B200 capacity, weights provenance, and lineage capture for regulatory reproducibility.
• Epidemiologist / public-health analyst — runs surveillance against aggregated symptom, syndromic, and lab data; LLM summarisation of the daily situation report. Cares about residency, de-identification, and citation back to the source feed.
• Trust admin / clinical governance lead — owns the answer-quality dashboard, the override-rate review, the knowledge-base refresh cadence, and the demographic post-market monitoring required under MHRA and FDA guidance.
• IT and identity counterpart — owns OIDC federation, SCIM provisioning, EHR connector wiring, audit-export bucket configuration, and the customer-managed KMS keys. Does not see clinical content.

Common workloads#

These are the workloads Yobitel sees in production across NHS trusts, US health systems, EU regulated trusts, and life-sciences customers in 2025-26. MediQuery covers the clinical-decision-support core; the AI Applications partner suite extends into oncology MDT, radiology triage, ambient documentation, and prior-authorisation; Yobibyte hosts customer-built apps for everything else.

• Clinical decision support — bedside Q&A grounded in the patient's chart plus guidelines (NICE, BNF, UpToDate, Cochrane, DynaMed, ClinicalKey) with citation rendering, evidence-grade tags, refusal when sources are thin, and an immutable audit trail. This is MediQuery's headline workload.
• Ambient clinical documentation — passive multi-speaker listening structured into SOAP note, problem list, ICD-10 / SNOMED-CT coded diagnoses, and proposed orders for clinician sign-off. Whisper-derived ASR with diarisation; speaker-attributed transcripts.
• Imaging triage — stroke (LVO), pulmonary embolism, pneumothorax, intracranial haemorrhage, and aortic dissection prioritisation on the radiology worklist. CT, MR, CXR, mammography, and retinal screening; DICOM SR output back to PACS.
• Digital pathology — whole-slide image analysis for prostate, breast, and dermatopathology; AI-assisted screening with pathologist sign-off.
• Prior-authorisation automation — medical-necessity extraction from the clinical record against payer policy retrieval, X12 278 round-trip, denial-reason triage, and analyst-assist for appeals. Common in US health systems and large payer organisations.
• Drug-drug interaction and order-entry safety — real-time DDI, dose-by-weight, renal/hepatic adjustment, allergy cross-check against formulary; supported by the BNF / DrugBank / RxNorm connectors.
• Drug discovery and translational — molecular generation with property objectives, protein-language scoring (ESM-2, ProGen2), retrosynthesis routing, and synthetic-control augmentation for trial design. Runs on ephemeral Yobitel NeoCloud H100 / H200 / B200 fleets under customer-managed keys.
• Pharmacovigilance and signal detection — adverse-event extraction from spontaneous reports, social-media listening (where lawful), and EHR free text; signal triage feeding the MHRA Yellow Card and FDA FAERS pipelines.
• Clinical trial matching — inclusion / exclusion logic across structured criteria plus free-text notes, returning consented sites. Increasingly embedded in oncology MDT workflows.
• Claims fraud and SIU — graph-based typology detection (upcoding, unbundling, phantom billing, phantom providers) with LLM-enriched case files for investigator assist.
• Population-health stratification — risk-of-readmission, risk-of-deterioration, frailty index, and unmet-need cohort identification, often run by ICS / payer analytics teams against linked datasets under sector-specific lawful basis.
• Operational workflow — bed management, theatre scheduling, no-show prediction, revenue-cycle automation, and rota planning.

Data integrations#

Integration is the work in healthcare AI; the model is the last 10%. Yobitel's healthcare deployments stand or fall on EHR connector fidelity, imaging-PACS integration, payer-pipeline plumbing, and the right coding vocabularies plumbed end-to-end. The connectors below are the production integration surface in MediQuery, the partner AI Applications suite, and the Yobibyte connector catalogue.

• EHR (UK primary care) — EMIS Web and TPP SystmOne via GP Connect FHIR R4 and the IM1 pairing pattern where required. Patient demographics, problems, medications, allergies, observations, immunisations, and document references.
• EHR (UK secondary care) — Epic Hyperdrive, Cerner Millennium, System C Medway, InterSystems TrakCare, Allscripts Sunrise via FHIR R4. NHS Number resolution through the Personal Demographics Service (PDS) FHIR endpoint.
• EHR (US) — Epic (App Orchard / Showroom), Cerner / Oracle Health (Code), Meditech Expanse (Greenfield), Athenahealth, Allscripts Veradigm via FHIR R4 plus SMART on FHIR launch context for clinician-bound apps.
• EHR (EU) — Dedalus DXC, ChipSoft HiX, CompuGroup, Cerner via FHIR R4 inside the EU Data Boundary.
• Legacy HL7v2 — ADT (A01 / A03 / A08), ORM, ORU, MDM, and SIU messages over MLLP for estates not yet on FHIR. Ingested into the same canonical patient model.
• Imaging — DICOM C-FIND / C-MOVE / C-STORE against PACS and Vendor Neutral Archives (Sectra, Agfa Enterprise Imaging, Change Healthcare, GE TrueImage); HL7 ORM / ORU against the RIS; DICOM SR / GSPS write-back for AI-derived findings.
• Coding vocabularies — SNOMED-CT (UK Edition, US Edition, International), ICD-10 (WHO), ICD-10-CM / ICD-10-PCS (US), OPCS-4 (UK procedures), LOINC for labs, RxNorm for US medications, dm+d for UK medications, ICD-O-3 for oncology.
• Knowledge sources — NICE guidance, BNF, BNFc, MHRA safety alerts, FDA drug labels, DrugBank, UpToDate, ClinicalKey, DynaMed, Cochrane, PubMed, ClinicalTrials.gov. Each connector respects its source's licensing — the customer holds the relevant subscription where required.
• Payer pipeline — X12 270 / 271 (eligibility), 278 (authorisation), 837 (claim), 835 (remittance) for US payers; CDA C-CDA for cross-system clinical document exchange.
• Public-health feeds — UKHSA syndromic and laboratory surveillance, CDC NSSP, ECDC Surveillance Atlas, WHO outbreak intelligence; ingested for population-health and outbreak-response apps built on Yobibyte.
• Identity-resolved linkage — NHS Number (PDS), MPI / EMPI for US health systems, and patient-id assignment authorities for cross-trust linkage.

Identity and RBAC#

Healthcare identity is OIDC-first and group-driven. MediQuery and the AI Applications partner suite federate to the customer's identity provider; there is no application-local user database. Customer-built apps on Yobibyte inherit the same OIDC pattern through the platform's workspace identity surface.

Five identity providers cover the vast majority of customer estates today: NHS Care Identity (formerly Smartcard / NHS CIS2) for NHS trusts, Epic Hyperdrive SSO for Epic-led US health systems, Microsoft Entra ID for the Microsoft 365-heavy estates, Okta for the multi-IdP federations, and Keycloak for self-hosted academic and research estates. SCIM 2.0 provisioning is supported across all of them; customers that do not run SCIM map groups manually through the operator console.

Clinical RBAC follows the hierarchy the customer already operates. The customer maps IdP group IDs onto roles — consultant, registrar / resident, specialty trainee, nurse, advanced clinical practitioner, pharmacist, allied health professional, MDT lead, radiologist, pathologist, oncologist, RCM analyst, claims investigator, trust admin, governance lead, IT and identity counterpart — and each role carries default knowledge-surface ordering, answer-framing posture, EHR field access scope, and PHI redaction policy. A registrar querying the antimicrobial guideline sees a different default ranking than a consultant on a complex case, and a nurse opening a patient context sees the fields a nurse role is authorised to read, not the full record.

Break-glass is a first-class clinical RBAC primitive, not an afterthought. A consultant facing a deteriorating patient with an out-of-hours role mismatch triggers an explicit break-glass action, supplies a structured reason, and the audit trail captures the elevated session as a discrete event flagged for governance review within 24 hours. Ambiguous group memberships (a user in two groups that map to different roles) surface a banner to the clinician and a ticket to the admin until resolved. Every authentication, role resolution, patient-context open, knowledge-source retrieval, EHR field read, and override is recorded in the immutable audit trail with the clinician's identity, the trust's session context, and the cryptographic chain that links them.

Deployment modes#

Healthcare AI sovereignty is non-negotiable, and the deployment mode is the headline procurement decision. Yobitel supports three modes across MediQuery, the partner AI Applications suite, and Yobibyte. The clinician and analyst-facing experience is identical across all three; the differences are sovereignty pin, connector availability, and where the runtime physically sits.

• Managed multi-tenant on Yobitel NeoCloud — the default for most NHS trusts, EU regulated trusts, and US health systems. The customer gets an isolated tenant inside a Yobitel-operated sovereignty region (UK NCSC OFFICIAL for the standard NHS posture, OFFICIAL-SENSITIVE for higher-classification estates, EU Data Boundary for EU trusts, HIPAA-aligned partner regions for US health systems). Set-up to first clinical use is typically four to six weeks for MediQuery and the partner suite, and eight to twelve weeks for customer-built Yobibyte apps depending on the integration scope.
• Dedicated single-tenant on Yobitel NeoCloud — for trusts and health systems that require sole-tenant infrastructure for procurement or compliance reasons. Same managed posture, separate underlying capacity, per-customer performance and noisy-neighbour guarantees. Common in US health systems where the BAA scope mandates sole tenancy and in UK trusts running OFFICIAL-SENSITIVE workloads against the NCSC Cloud Security Principles' separation-of-tenants principle.
• Air-gapped on-premise — for regulated trusts, classified research institutions, and the most sensitive defence-health estates where no external network egress is permitted. Yobitel deploys the runtime into a customer-owned or Yobitel-operated on-premise enclave; knowledge sources are uploaded directly; the EHR connection is local; audit export writes to an on-premise object store; connectors that depend on external APIs (PubMed, UpToDate, DrugBank) are replaced with local mirrors maintained by the customer on a quarterly refresh cycle. Hardware delivery is via NeoCloud Operations or the customer's own estate.

Compliance posture#

Healthcare compliance is layered. UK frameworks lead for NHS trust and UK independent provider deployments; EU frameworks layer in for EU trusts; US frameworks layer in for US health systems and payers; SaMD frameworks (MHRA, FDA, MDR / IVDR) apply when the workload influences diagnosis or treatment. Yobitel treats the compliance posture as a first-class product feature and maintains the evidence pack — not a slide.

• NCSC Cloud Security Principles — Yobitel NeoCloud UK regions map controls to all 14 principles with evidence available under NDA.
• NHS Data Security and Protection Toolkit — Yobitel maintains the DSP Toolkit posture for the UK NeoCloud regions that host MediQuery, the AI Applications suite, and Yobibyte clinical workspaces.
• NHS DTAC — MediQuery is DTAC-assessed; partner applications in the AI Applications suite carry their own DTAC evidence.
• GDPR / UK DPA 2018 — DPA, sub-processor list, EU SCCs, and Article 28 processor obligations are part of the standard contract.
• EU AI Act — high-risk clinical-decision-support obligations met by default in MediQuery through citation rendering, override path, and the immutable audit trail.
• HIPAA — Yobitel signs a BAA with covered entities and business associates; PHI encryption (AES-256 at rest, TLS 1.3 in transit), access logging, and audit retention meet covered-entity expectations.
• FDA SaMD — partner applications classified as SaMD carry their own 510(k) / De Novo / PMA evidence; Yobitel hosts under the partner's quality management system.
• MHRA — applications classified as Software and AI as a Medical Device follow the MHRA roadmap; MHRA AI Airlock testing is supported for candidate apps.
• G-Cloud — Yobitel is listed under Cloud Software and Cloud Support for MediQuery, the AI Applications suite, NeoCloud, and Yobibyte workspaces; orderable through the Crown Commercial Service framework.
• SOC 2 Type II — annual third-party audit covering security, availability, confidentiality, processing integrity, and privacy.
• ISO 27001:2022 — current certificate covering the NeoCloud estate, the Yobibyte platform surface, and the AI Applications managed plane.

Outcomes#

Successful healthcare AI rollouts cluster around four leading indicators in MediQuery and Yobitel AI Applications partner deployments. Customers that hit these in the first 90 days typically convert from pilot to estate-wide rollout without escalation.

Citation coverage above 92% of clinical answers — every claim in the answer maps back to at least one source the customer has authorised. This is the headline answer-quality signal; below this band the application is generating content the customer cannot defend in front of their governance committee.

Override rate at or below 10% for routine queries — clinicians accept the cited recommendation without amendment for the majority of straightforward lookups, and overrides on complex cases carry a structured reason that feeds the next knowledge-base refresh cycle. A persistent spike above 15% on a specific topic means the underlying knowledge source is stale or missing.

Clinician usage at 60-80% of licensed seats actively engaged each week — pilots that struggle to reach 40% usage usually have a knowledge-base or default-surface problem (the clinician's first question did not find a satisfying answer), not a model problem. The trusts and health systems with the strongest usage typically run a clinical-champion model where consultants in each specialty nominate the first three knowledge sources for their team.

Time returned per clinician — self-reported and corroborated by EHR session-length data, typical deployments report 20-40 minutes per clinician per shift returned to direct patient time as routine lookups collapse from minutes to seconds. For radiology triage, time-to-treatment reductions on stroke and PE pathways are the equivalent measure. For prior-authorisation, the headline indicator is approvals per analyst per hour and reduction in denial rate.

InferenceBench, Yobitel's open methodology for ranking model quality, latency, and cost, grounds the model selection inside the Yobibyte marketplace that powers all three surfaces. Customers can independently verify which model is recommended for clinical-decision support, ambient documentation, or radiology triage at any point, rather than trusting a vendor narrative.

Where it fits in the Yobitel stack#

Healthcare customers consume Yobitel through three surfaces, each with a different level of customer engineering effort and a different level of clinical workflow opinion.

MediQuery is the flagship clinical AI application. It is the fastest path to production for clinical decision support, EHR-grounded clinical Q&A, ambient documentation (when bundled), and DDI safety. The customer configures a knowledge base, wires an EHR connector, maps clinical RBAC onto their IdP groups, and clinicians use it; Yobitel operates everything underneath. Pricing is per-clinician-per-month in USD across standard, premium, and air-gapped tiers.

The wider Yobitel AI Applications suite hosts partner clinical and life-sciences apps for oncology MDT, radiology triage, ambient scribing, prior-authorisation, pharmacovigilance, and clinical-trial matching. Each partner app inherits the same sovereignty bar (UK NCSC, EU Data Boundary, US HIPAA, air-gapped) and the same identity / RBAC pattern; the customer chooses which partner to procure and Yobitel hosts under the partner's quality management system.

Yobibyte is the managed platform on which the customer's own engineering or data-science team builds bespoke clinical, payer, life-sciences, or public-health apps — population-health analytics, internal pharmacovigilance pipelines, discovery workflows, claims fraud graphs, syndromic surveillance dashboards. The customer brings the model, the data, and the evaluation harness; Yobibyte provides the workspace, the inference surface, the marketplace of vetted models (grounded against InferenceBench), and the regulatory primitives (audit trail, customer-managed keys, residency pin). The runtime is Yobitel-operated; the customer is not exposed to underlying accelerators or inference engines.

Underneath, Yobitel NeoCloud is the sovereign, Tier III+ GPU estate that hosts all three surfaces — UK NCSC OFFICIAL primary regions for the NHS posture, NCSC OFFICIAL-SENSITIVE for higher-classification estates, EU Data Boundary regions, HIPAA-aligned partner regions for US health systems, and on-premise enclaves for the most sensitive estates. NeoCloud Operations runs the 24/7 NOC and the underlying GPU lifecycle; Managed Operations runs the customer's own infrastructure where they want Yobitel ops on their estate. Customer Excellency owns the relationship; Professional Services delivers bespoke integration work (custom EHR connectors, trust-specific knowledge-base builds, on-premise hardware delivery, SaMD-pathway support); Training Services builds the clinical and operator cohorts. Omniscient Compute provides elastic capacity routing for discovery and translational workloads that need ephemeral H100 / H200 / B200 fleets, inside the customer's sovereignty boundary at all times.